University of Miami Sylvester Comprehensive Cancer Center

 

Lymphoma
10:08

2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: Loncastuximab Tesirine and Rituximab in High-Risk R/R Follicular Lymphoma

FEATURING Juan Alderuccio
  • December 17, 2024
22:04

University of Miami Sylvester Comprehensive Cancer Center

MZL: Current Management and Emerging Therapeutics

FEATURING Izidore Lossos
  • 59 views
  • September 27, 2024
08:42

University of Miami Sylvester Comprehensive Cancer Center

Optimizing Early Stage HL Treatment: Eliminating or Replacing Radiation With Brentuximab Vedotin"

FEATURING Craig Moskowitz
  • 30 views
  • August 9, 2024
10:52

University of Miami Sylvester Comprehensive Cancer Center

Current Treatment of 1L Hodgkin Lymphoma

FEATURING Craig Moskowitz
  • 500 views
  • August 2, 2024
  • 2
07:41

University of Miami Sylvester Comprehensive Cancer Center

Using BTKis in MCL Today

FEATURING Alvaro Alencar
  • 66 views
  • May 7, 2024
09:10

University of Miami Sylvester Comprehensive Cancer Center

Evaluating Zanubrutinib + Tafasitamab in MCL

FEATURING Alvaro Alencar
  • 25 views
  • May 7, 2024
27:01

University of Miami Sylvester Comprehensive Cancer Center

Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role of Radiotherapy, BV + AVD Study and Nivolumab Study

FEATURING Craig Moskowitz
  • 268 views
  • November 19, 2018